Trials / Conditions / Hyperphosphatemia Patients on Hemodialysis
Hyperphosphatemia Patients on Hemodialysis
5 registered clinical trials studyying Hyperphosphatemia Patients on Hemodialysis — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders NCT07285291 | Taisho Pharmaceutical Co., Ltd. | Phase 3 |
| Recruiting | A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis NCT07285304 | Taisho Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis NCT06745531 | Taisho Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders NCT06745518 | Taisho Pharmaceutical Co., Ltd. | Phase 2 |
| Completed | A Phase 2 Dose-finding Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis NCT05699239 | Taisho Pharmaceutical Co., Ltd. | Phase 2 |